16,569 Shares in Doximity, Inc. (NASDAQ:DOCS) Acquired by Hsbc Holdings PLC

Hsbc Holdings PLC bought a new position in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 16,569 shares of the company's stock, valued at approximately $891,000.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Stifel Financial Corp raised its position in shares of Doximity by 4.5% during the fourth quarter. Stifel Financial Corp now owns 51,902 shares of the company's stock worth $2,771,000 after acquiring an additional 2,228 shares during the last quarter. Tower Research Capital LLC TRC raised its holdings in Doximity by 348.6% during the 4th quarter. Tower Research Capital LLC TRC now owns 7,972 shares of the company's stock worth $426,000 after purchasing an additional 6,195 shares during the last quarter. MetLife Investment Management LLC lifted its position in shares of Doximity by 11.5% in the 4th quarter. MetLife Investment Management LLC now owns 72,540 shares of the company's stock worth $3,873,000 after purchasing an additional 7,476 shares during the period. BI Asset Management Fondsmaeglerselskab A S bought a new stake in shares of Doximity in the 4th quarter valued at $169,000. Finally, Dimensional Fund Advisors LP increased its position in shares of Doximity by 4.2% during the fourth quarter. Dimensional Fund Advisors LP now owns 1,576,455 shares of the company's stock worth $84,167,000 after buying an additional 63,815 shares during the period. 87.19% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Doximity news, CFO Anna Bryson sold 45,000 shares of Doximity stock in a transaction dated Thursday, May 1st. The shares were sold at an average price of $57.23, for a total value of $2,575,350.00. Following the sale, the chief financial officer now owns 357,165 shares of the company's stock, valued at approximately $20,440,552.95. The trade was a 11.19 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Kira Scherer Wampler sold 2,000 shares of the stock in a transaction that occurred on Thursday, May 1st. The shares were sold at an average price of $56.93, for a total transaction of $113,860.00. Following the transaction, the director now directly owns 16,618 shares of the company's stock, valued at $946,062.74. This represents a 10.74 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 37.40% of the company's stock.

Doximity Price Performance

Shares of NASDAQ DOCS traded up $0.98 during midday trading on Thursday, reaching $59.34. The company's stock had a trading volume of 1,771,715 shares, compared to its average volume of 2,007,978. The stock has a market capitalization of $11.08 billion, a P/E ratio of 59.34, a PEG ratio of 4.10 and a beta of 1.41. The firm has a 50 day moving average price of $58.34 and a 200-day moving average price of $56.91. Doximity, Inc. has a 12-month low of $22.96 and a 12-month high of $85.21.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on DOCS shares. Morgan Stanley dropped their target price on shares of Doximity from $71.00 to $60.00 and set an "equal weight" rating on the stock in a report on Thursday, April 24th. The Goldman Sachs Group upped their target price on Doximity from $58.00 to $80.00 and gave the company a "neutral" rating in a research report on Monday, February 10th. Raymond James reissued an "outperform" rating and issued a $83.00 price target (up from $65.00) on shares of Doximity in a research note on Friday, February 7th. Canaccord Genuity Group increased their price target on Doximity from $60.00 to $71.00 and gave the stock a "hold" rating in a report on Friday, February 7th. Finally, Wells Fargo & Company reiterated an "equal weight" rating on shares of Doximity in a research note on Friday, February 7th. Eleven equities research analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, Doximity presently has a consensus rating of "Moderate Buy" and a consensus price target of $65.39.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.